NDC 72607-100

TAZVERIK

Tazemetostat

TAZVERIK is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Epizyme, Inc.. The primary component is Tazemetostat Hydrobromide.

• Product ID: 72607-100_235cbcdb-e700-429c-9130-6a512a146c54
• NDC: 72607-100
• Product Type: Human Prescription Drug
• Proprietary Name: TAZVERIK
• Generic Name: Tazemetostat
• Dosage Form: Tablet, Film Coated
• Route of Administration: ORAL
• Marketing Start Date: 2020-01-23
• Marketing Category: NDA / NDA
• Application Number: NDA211723
• Labeler Name: Epizyme, Inc.
• Substance Name: TAZEMETOSTAT HYDROBROMIDE
• Active Ingredient Strength: 200 mg/1
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 72607-100-00

240 TABLET, FILM COATED in 1 BOTTLE (72607-100-00)

• Marketing Start Date: 2020-01-23
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 72607-100-00 [72607010000]

TAZVERIK TABLET, FILM COATED

• Marketing Category: NDA
• Application Number: NDA211723
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2020-01-23

Drug Details

Active Ingredients

Ingredient	Strength
TAZEMETOSTAT HYDROBROMIDE	200 mg/1